z-logo
open-access-imgOpen Access
A different approach to tumour suppression: The Alexandra Kefalides Memorial Lecture
Author(s) -
Henry Harris,
Joy P. Rawlins,
Jane Sharps
Publication year - 1996
Publication title -
journal of cell science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.384
H-Index - 278
eISSN - 1477-9137
pISSN - 0021-9533
DOI - 10.1242/jcs.109.9.2189
Subject(s) - keratin , biology , keratinocyte , context (archaeology) , keratin 8 , lineage (genetic) , keratin 14 , keratin 7 , microbiology and biotechnology , in vivo , intermediate filament , cell , in vitro , immunology , genetics , cytokeratin , cytoskeleton , gene , immunohistochemistry , transgene , genetically modified mouse , paleontology
When tumour cells are fused with normal ones, malignancy is suppressed. It has been shown that this suppression is associated with the imposition on the hybrid cell of the terminal differentiation programme of the normal parent cell. We report here the consequences of imposing the synthesis of keratin 1 and keratin 10, markers of terminal differentiation in the epidermal keratinocyte, on malignant cells of keratinocyte and non-keratinocyte lineage. We find that there is extreme selection in vivo against cells making keratin 1: tumours arising from inocula of such cells are invariably produced by the selective overgrowth of cells in which keratin 1 synthesis has been drastically reduced, usually to trace levels. No such selection operates against keratin 10. It is possible that if substantial synthesis of keratin 1 could be induced in malignant cells in a clinical context, some therapeutic benefit might accrue.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom